Internal medicine

Receptor

Virus

Tocilizumab

Disease

Coronavirus disease 2019 (COVID-19)

Infectious disease (medical specialty)

Outbreak

Antigen

Virology

Rheumatology

Immunology

Rheumatoid arthritis

T cell

2019-20 coronavirus outbreak

Cytokine release syndrome

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Chimeric antigen receptor

Medicine

Immune system

Expert Opinion on Biological Therapy

KEYWORDS: Chimeric antigen receptor (CAR) T cell‐induced cytokine release syndromecoronavirusCOVID-19inflammationinterleukin-6macrophage activation syndrometocilizumabanakinracolchicine

Tocilizumab: from the rheumatology practice to the fight against COVID-19, a virus infection with multiple faces